CDC says J&J vaccine has ‘small possible risk’ of rare neurological disorder

Johnson & Johnson’s COVID-19 vaccine may pose a “small possible risk” of Guillain-Barré syndrome, a rare but potentially dangerous neurological reaction, U.S. health officials said Monday.

Georgia tax revenue leaps more than $3B over last year

Georgia’s state tax receipts jumped by more than $3 billion in the budget year ended June 30, Gov. Brian Kemp announced Monday, setting up an election-year session in which lawmakers will have many options for new spending or tax cuts.

Kids age 1 to 4 most at risk for drowning death, American Academy of Pediatrics study finds

A new report by the Amerian Academy of Pediatrics found that children between the ages of 1 and 4 are at the highest risk of die from drowning, followed by teens between 15 and 19 who were mostly male.

Georgia schools invited to apply for tests of lead in water

A group that will test for lead in drinking water at Georgia public schools is inviting schools to apply for the testing program.

Fire departments tackle a new foe in fighting blazes: cancer

For decades, American firefighters have been developing cancer at higher rates than people in other professions, many after decades of service. Veteran firefighter Jason Shivers says the elevated cancer risk was seen by some as "the cost of doing business." That attitude is changing in places like Forsyth County, Georgia.

Pfizer to discuss booster shots with US health officials Monday

Pfizer says it plans to meet with top U.S. health officials Monday to discuss the drugmaker’s request for federal authorization of a third dose of its COVID-19 vaccine.

Team USA gold medal favorite is refusing vaccination ahead of Olympic Games

The event is set to start on July 23, with no spectators planned to attend the event due to an ongoing spike in COVID cases challenging Tokyo.

Aduhelm: FDA head calls for review of Alzheimer's drug

Dr. Janet Woodcock, the acting head of the FDA, is calling for a review of highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug.

Several countries in Asia reinstate COVID-19 restrictions amid rapid infections

Several countries around Asia and the Pacific that are experiencing their first major surges of the coronavirus have rushed to implement tough restrictions.

CHOA patients become NASCAR driver's honorary pit crew

Four patients at Children's Healthcare of Atlanta got to spend their day gearing up for Sunday's NASCAR race.

Georgia marijuana regulator gets closer to issuing licenses

Georgia regulators say they are very close to issuing licenses to grow medical marijuana, but they aren't quite there yet.

US death rates fall for lung cancer, melanoma, report says

U.S. death rates from many types of cancer continued to decline, mostly in deaths from lung cancer and melanoma, according to a new report published Thursday.

Current COVID-19 vaccine program has saved nearly 300K lives, researchers estimate

A recent study from the Yale School of Public Health and the Commonwealth Fund estimates that without the current COVID-19 vaccine program, the U.S. would have added nearly 300,000 more people to its death toll.

Pfizer booster shot: COVID-19 vaccine maker to seek approval for 3rd dose

The company said Thursday that another shot could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.

Fauci says all 3 COVID-19 vaccines effective against delta variant

The delta variant is spreading in the U.S., particularly in areas with low vaccination rates, and has become the most dominant strain in the country.